ORAGENICS, Inc.

Home » ORAGENICS, Inc.

Secondary

ORAGENICS, Inc.

We are focused on becoming a leader in developing novel antibiotics against infectious disease and on developing effective treatments for oral mucositis.

Symbol

OGEN

Last Closing Price
$1.53

Shares
TBD

Anticipated Date
TBD

Underwriters
Ladenburg Thalmann

To view the prospectus for ORAGENICS, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253